Research Excellence Award
Milana Frenkel-Morgenstern
Reichman University, Israel
The Research Excellence Award recognizes the scholarly and scientific contributions of Milana Frenkel-Morgenstern in the fields of oncology, computational biology, and precision medicine. Her interdisciplinary research has contributed to advancements in cancer genomics, RNA biology, and translational biomedical research, particularly through the integration of bioinformatics and molecular oncology methodologies.[1] The academic profile associated with this recognition reflects sustained publication activity, significant citation impact, and active participation in global oncology research initiatives.[2]
Abstract
Milana Frenkel-Morgenstern has established a multidisciplinary academic profile centered on computational oncology, molecular interactions, and precision medicine. Her research activities have focused on the development of bioinformatics frameworks capable of identifying molecular signatures associated with cancer progression and therapeutic response.[1] Through collaborative scientific initiatives, her publications have contributed to the understanding of alternative splicing, RNA interactions, and predictive cancer biomarkers relevant to modern oncology research.[3]
Keywords
- Oncology
- Precision Medicine
- Cancer Genomics
- Bioinformatics
- RNA Biology
- Computational Biology
- Molecular Oncology
- Biomarker Discovery
Introduction
The emergence of precision oncology has significantly transformed the landscape of cancer diagnosis and therapeutic development. Researchers working at the interface of computational science and biomedical investigation have played an important role in advancing personalized treatment strategies.[2] Milana Frenkel-Morgenstern has contributed to this evolving field through research addressing molecular mechanisms involved in cancer biology and genomic regulation.[4]
Her academic contributions are associated with large-scale computational analyses and integrative biomedical studies designed to identify clinically relevant molecular interactions. Such work has relevance in translational oncology and contributes to broader scientific efforts aimed at improving precision-based therapeutic approaches.[3]
Research Profile
Milana Frenkel-Morgenstern is affiliated with Reichman University in Israel and maintains an established research portfolio indexed within international scientific databases. According to Scopus author metrics, the researcher has produced more than one hundred scholarly documents with a substantial citation record and measurable research influence reflected by an h-index of 34.[1]
The research profile demonstrates active engagement in interdisciplinary scientific collaborations, particularly in oncology, molecular genetics, systems biology, and computational medicine. Her work frequently combines experimental and computational methodologies to explore disease mechanisms and biological networks.[4]
Research Contributions
Among the notable scientific contributions associated with the researcher are investigations into RNA-mediated regulation, alternative splicing events, and protein interaction networks relevant to cancer progression.[3] These studies contribute to the understanding of how molecular alterations may influence disease development and therapeutic responsiveness in oncology.
- Development of computational methods for cancer-related genomic analysis.
- Research on RNA interactions and molecular regulatory pathways.
- Integration of bioinformatics approaches in precision oncology studies.
- Collaborative interdisciplinary publications in translational medicine.
- Contributions to predictive biomarker identification in cancer research.
Publications
The publication record associated with Milana Frenkel-Morgenstern includes peer-reviewed journal articles, collaborative studies, and computational oncology research papers indexed in international scientific databases.[1] Representative publication themes include systems biology, RNA splicing, protein interaction analysis, and cancer informatics.
- Computational approaches to RNA interaction mapping in cancer biology.
- Bioinformatics analysis of alternative splicing mechanisms in oncology.
- Precision medicine frameworks for translational cancer research.
- Systems biology methodologies for molecular network prediction.
Several research outputs are linked to DOI-indexed scholarly publications, supporting scientific reproducibility and accessibility within the international research community.[5]
Research Impact
The research impact associated with Milana Frenkel-Morgenstern is reflected through citation performance, interdisciplinary collaborations, and continued engagement in oncology-related scientific investigations.[1] Her citation metrics indicate sustained academic relevance across areas involving molecular medicine, computational biology, and translational cancer research.
The integration of computational approaches into oncology research contributes to broader efforts aimed at improving biomarker discovery, treatment personalization, and molecular diagnostics.[4] Such contributions support ongoing advancements in precision medicine frameworks within global biomedical research environments.
Award Suitability
The academic achievements of Milana Frenkel-Morgenstern align with the objectives of the International Research Awards on Oncology and Cancer Research. The researcher’s interdisciplinary focus, publication productivity, and measurable citation influence demonstrate a sustained commitment to scientific advancement in oncology and precision medicine.[2]
The recognition of contributions related to computational oncology and molecular research supports the broader mission of promoting innovative and evidence-based scientific developments within the international cancer research community.[3]
Conclusion
Milana Frenkel-Morgenstern has developed an internationally visible academic profile through contributions to oncology, computational biology, and precision medicine. Her scientific output, citation performance, and interdisciplinary collaborations demonstrate active engagement in contemporary cancer research initiatives.[1] The Research Excellence Award acknowledges these scholarly contributions and highlights the continuing importance of integrative biomedical research within modern oncology.
External Links
References
- Elsevier. (n.d.). Scopus author details: Milana Frenkel-Morgenstern, Author ID 8528967600. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=8528967600
- International Research Awards on Oncology and Cancer Research. (n.d.). Official Award Information and Research Recognition Platform.
https://oncology.pencis.com/
- Frenkel-Morgenstern, M. et al. (2020). Computational and molecular insights in cancer systems biology. Cell Reports.
DOI:https://doi.org/10.1016/j.celrep.2020.107806
- ORCID. (n.d.). Research profile of Milana Frenkel-Morgenstern.
https://orcid.org/0000-0002-0329-4599
- DOI Foundation. (n.d.). Digital Object Identifier reference database for oncology publications.
https://doi.org/